Cargando…

1457. Escherichia coli Community Acquired Pneumonia

BACKGROUND: Escherichia coli has been thought to be an uncommon cause of community-acquired pneumonia (CAP). Large epidemiological data on E. coli CAP (E-CAP) and its comparison to pneumococcal CAP (P-CAP) are lacking. METHODS: A multi-center retrospective cohort study of adult patients (aged ≥ 18 y...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Teny Mathew, Deshpande, Abhishek, Haessler, Sarah, Brizendine, Kyle, Yu, Pei-Chun, Imrey, Peter, Rothberg, Michael B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252561/ http://dx.doi.org/10.1093/ofid/ofy210.1287

Ejemplares similares

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

1469. Microbial Etiology of Community-Acquired Pneumonia Requiring Hospitalization Among US Adults
por: Deshpande, Abhishek, et al.
Publicado: (2018)

De-escalation of Broad Spectrum Antibiotics Following Negative Cultures in Pneumonia: Rates and Outcomes
por: Deshpande, Abhishek, et al.
Publicado: (2017)

1501. Risk Factors for Clostridium difficile Infection in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022)

2206. Patterns of Care and Outcomes in Elderly Patients Hospitalized with Community-acquired Pneumonia in the United States
por: Rastogi, Radhika, et al.
Publicado: (2019)

2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
por: Bartley, Patricia, et al.
Publicado: (2019)

2794. Testing and Treatment in Patients Hospitalized with Suspected Influenza Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia
por: Gupta, Niyati M., et al.
Publicado: (2019)

1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020)

Assessment of the Accuracy of Using ICD-9 Diagnosis Codes to Identify Pneumonia Etiology in Patients Hospitalized With Pneumonia
por: Higgins, Thomas L., et al.
Publicado: (2020)

A risk model to identify Legionella among patients admitted with community‐acquired pneumonia: A retrospective cohort study
por: Rothberg, Michael B., et al.
Publicado: (2022)

2603. Acceptance of Pharmacist-Led Stewardship Recommendations for Patients with Community-Acquired Pneumonia
por: Walker, Ramara E, et al.
Publicado: (2023)

1457. Serial Passage of Enterobacteriaceae to Explore Development of Carbapenem Resistance
por: Nissim, Yosef, et al.
Publicado: (2020)

A Red Flag for Community-Acquired Pneumonia in the Elderly
por: Panchabhai, Tanmay S., et al.
Publicado: (2015)

1457 Febrile Illness at a State Correctional Facility — Illinois, 2013
por: Arwady, M. Allison, et al.
Publicado: (2014)

Derivation and external validation of a prediction model for pneumococcal urinary antigen test positivity in patients with community-acquired pneumonia
por: Kim, Priscilla, et al.
Publicado: (2023)

Complete Genome Sequence of Staphylococcus epidermidis 1457
por: Galac, Madeline R., et al.
Publicado: (2017)

Pneumococcal Urinary Antigen Testing in US Hospitals: Underutilized and Rarely Acted Upon
por: Haessler, Sarah, et al.
Publicado: (2017)

1457. Antimicrobial Resistance of Urinary Tract Infection Pathogens in South Korea: A Surveillance Report of the One-Year Assessment in 2017
por: Liu, Changseung, et al.
Publicado: (2019)

2193. Factors Impacting the Duration of Antimicrobial Therapy for Community-Acquired Pneumonia
por: Sandhu, Avnish, et al.
Publicado: (2019)

Comparative analyses of Campylobacter concisusstrains reveal the genome of the reference strain BAA-1457 is not representative of the species
por: Kaakoush, Nadeem O, et al.
Publicado: (2011)

1457. Carbapenem-resistant Acinetobacter baumannii in an Intensive Care Unit during the COVID-19 pandemic: An Outbreak Investigation Utilizing Whole Genome Sequencing
por: Williams, Samantha, et al.
Publicado: (2023)

P1457: MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Escherichia coli and Community-acquired Gastroenteritis, Melbourne, Australia
por: Robins-Browne, Roy M., et al.
Publicado: (2004)

Invasive Mold Infections (IMI) among Liver Transplant Recipients (LTR): Is It Time to Reconsider the Risk Factors that Determine Antifungal Prophylaxis?
por: Neyra, Karyna, et al.
Publicado: (2017)

2590. Efficacy of Doxycycline Versus Azithromycin in Community Acquired Pneumonia
por: Mei, Julie, et al.
Publicado: (2023)

2210. Nasopharyngeal Detection of Streptococcus pneumoniae and Clinical Disease Severity in Children with Community-Acquired Pneumonia (CAP)
por: Wook Yun, Ki, et al.
Publicado: (2019)

1996. Invasive Fungal Infections in Orthotopic Heart Transplant: Incidence and Risk Factors in the Modern Era
por: Hasan, Lana, et al.
Publicado: (2023)

P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
por: Chua, Elaine, et al.
Publicado: (2023)

162. Assessment of Guideline-Concordant Testing for Legionella pneumophila and Streptococcus pneumoniae in Community-Acquired Pneumonia
por: Malik, Waleed, et al.
Publicado: (2022)

Stability of tuberous sclerosis complex 2 is controlled by methylation at R1457 and R1459
por: Gen, Seishu, et al.
Publicado: (2020)

2261. Impact of Antimicrobial Stewardship Program on Klebsiella pneumoniae and Escherichia coli Antimicrobial Resistance
por: Ferreiro, Jose Luis Lamas, et al.
Publicado: (2023)

1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia
por: Mergenhagen, Kari, et al.
Publicado: (2018)

1027. Vancomycin Use in Community-Acquired Pneumonia: Assessing Inappropriate Therapy
por: Shan, Timothy, et al.
Publicado: (2019)

2177. Institutional Prevalence of Drug-Resistant Pathogens in Community-Acquired Pneumonia
por: Ding, Helen, et al.
Publicado: (2022)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

792 Predictors of viral pneumonia in patients with community-acquired pneumonia
por: Kim, Ji Eun, et al.
Publicado: (2014)

Real-World Use – Isavuconazole at a Large Academic Medical Center
por: Hassouna, HabiBA, et al.
Publicado: (2017)

Impact of Personalized Audit and Feedback on Management of Pediatric Outpatient Community-Acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ahv8ib1f733d7t8lee9613atvi